NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
56 hedge funds and large institutions have $59.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 53 → 56 (+3)
Holders
56
Holding in Top 10
–
Calls
$145K
Puts
$1K
Top Buyers
| 1 | +$4.69M | |
| 2 | +$975K | |
| 3 | +$739K | |
| 4 |
SCM
Sio Capital Management
New York
|
+$739K |
| 5 |
Two Sigma Investments
New York
|
+$682K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$445K | |
| 3 | -$207K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$194K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$159K |